Raphael J. Wilson, M.D., FACIP, BCMAS

San Diego, California

512-***-**** ad36tp@r.postjobfree.com linkedin.com/in/raphael-wilson-md-1046284

DUAL-Board Certified Medical Affairs professional with extensive experience in R&D, medical strategies, and clinical operations. Proven track record as a leader and collaborator implementing creative problem resolution proficiency and strategic vision to optimize global collaborations across all pharma functions and project leadership to drive medical strategies. Experience includes assessing gap analysis among providers in medical communities to fulfill educational needs and expectations of providers and patients. Able to effectively establish, develop, and maintain strategic collaborations with clinicians, thought leaders and professional organizations in all therapeutic disciplines.

COMPETENCIES

Protocol Development Cardiovascular Medicine Pharmaceutical Research

Clinical Data Query Regulatory Safety Monitoring Clinical Liaison Clinical Trial Management

PROFESSIONAL EXPERIENCE

SANOFI US, Bridgewater, NJ October 2014 - Present

Senior Regional Medical Science Liaison-Cardiovascular

Share scientific and clinical data exceptionally well, communicating directly with Us healthcare providers and clinical researchers via appropriate scientific exchange, clinical research, disease state awareness education and medical educational gaps to inform healthcare providers and serving as a field-based scientific professional to facilitate research, education, or other collaborations. Territory includes Southern California, Inland Empire, NV, AZ

Identify Key Opinion Leaders (KOLs), Digital Opinion Leaders (DOL), and establish and maintain scientific relationships with KOLs and DOLs.

Identify and engage key external stakeholders with scientific expertise of Praluent (Alirocumab) and Multaq (Dronedarone). Territory includes Southern California, Inland Empire, NV, AZ

Advance field-based scientific professional for US Medical Affairs division of North American Pharmaceutical Operations.

Conduct pre-launch and launch initiatives prior to and following FDA approval for Praluent (Alirocumab).

AstraZeneca Pharmaceuticals LP., Wilmington, DE February 2014 - October 2014

Medical Science Liaison

Provided medical and scientific expertise and support for all marketed and pipeline products in metabolism in Southern California, Inland Empire, UT, and NV.

Identify and engage key external stakeholders with scientific expertise of Onglyza (Saxagliptin), Exenatide (Byetta, Bydureon), Symlin (Pramlintide), Farxiga (Dapagliflozin), and Myalept (Metreleptin).

Developed working relationships with international, national, regional, and local level endocrinologist, diabetologists, lipidologist, cardiologist and other KOLs with current, fair- balanced medical, scientific and pharmacoeconomic information.

Conducted pre-launch and launch initiatives prior to and following FDA approval for Farxiga (Dapagliflozin) and Myalept (Metreleptin).

Developed territory including developing relationships with internal and external stakeholders, appropriate therapeutic providers, academic faculty, managed care medical and pharmacy directors, as well as investigators.

Bristol-Myers Squibb Pharmaceuticals, Princeton, NJ February 2013 - February 2014

Medical Science Liaison

Territory includes Southern California, Inland Empire, UT, NV.

Continue to provide medical and scientific expertise and support for all marketed and pipeline products in metabolism in Southern California, Inland Empire, UT, and NV.

Identify and engage key external stakeholders with scientific expertise of Onglyza (Saxagliptin), Exenatide (Byetta, Bydureon), Symlin (Pramlintide), Farxiga (Dapagliflozin), and Myalept (Metreleptin).

Developed working relationships with international, national, regional, and local level endocrinologist, diabetologists, lipidologist, cardiologist and other KOLs with current, fair- balanced medical, scientific and pharmacoeconomic information.

Raphael J. Wilson ad36tp@r.postjobfree.com Page 2

(Continued)

Conducted pre-launch and launch initiatives prior to and following FDA approval for Farxiga (Dapsgliflozin) and Myalept (Metreleptin).

Identified and developed relationships with key thought leaders (TL) and other Health Care Providers (HCP) by engaging in ongoing scientific exchange and balanced discussions of science by addressing unsolicited questions on current medical and scientific issues, healthcare advances, treatment trends, and health outcomes measures.

Developed territory including developing relationships with internal and external stakeholders, appropriate therapeutic providers, academic faculty, managed care medical and pharmacy directors, as well as investigators.

California College San Diego-San Marcos Campus, San Diego, CA January 2013 - Present

Program Advisor

Help Enterprise, INC, San Diego, CA January 2011 - Present

Board Member January 2012 - Present

Medical Consultant January 2011 - Present

Metro Community Ministries, San Diego, CA January 2013 - 2018

Board Member January 2015 - 2018

Medical Consultant January 2013 – January 2015

Takeda Pharmaceuticals North America, Inc., Chicago, IL August 2008 - 2012

Senior Clinical Science Liaison

Served as health outcomes and value-added scientific expert with shared oversight to engage national and government organizations. Territory included Southern California, Inland Empire, AZ.

Identified and engaged key external stakeholders with scientific expertise of Actos (Pioglitazone) and Rozerem (Ramelteon).

Conducted pre-launch initiatives prior to FDA approval for Nesina (Alogliptin).

Conducted pre-launch and launch initiatives prior to and following FDA approval for Rozerem (Ramelteon).

Developed relationships with internal and external stakeholders, with cardio-metabolic therapeutic providers, academic faculty, managed care medical and pharmacy directors, as well as investigators.

Developed and conducted Medicare and Medicaid 3- and 5-minute managed care presentations to state medical boards in UT and NV as well as IDNs Med Impact, Merck-Medco, Pharmacy benefit managers, and specialty pharmacies.

Regional Scientific Manager August 2003 - 2008

Provided oversight of Thought Leader development, continuing and other Medical Education opportunities. Territory includes Southern California, Inland Empire, AZ.

Provided medical affairs support to Takeda Global Research and Development (TGRD) clinical trials program in the southwest region of the United States for the Cardio-Metabolic therapeutic group.

Identified and engaged key external stakeholders with scientific expertise of Actos (Pioglitazone)

RELEVANT EXPERIENCE

Fujisawa Healthcare Inc. (Astellas-2005), Deerfield, IL

Scientific Affairs Liaison

Identified, developed, and maintained collaborative relationships with emerging and current thought leaders in academic and clinical medicine in the South-Central Region of the United States. One of only 6 SALs for North America, territory included TX, LA, AL, OK, MO, NM, CO.

Ilex Oncology, San Antonio, TX

Clinical Research Associate – Clinical Project Manager

Managed and monitored multiple investigative sites in TX, LA, AL, OK, MO, NM, CO, FL, NC, TN, Toronto, Montreal, and Mississauga. Identified, developed, and maintained collaborative relationships with emerging and current investigative thought leaders in academic and clinical medicine conducting research in solid and liquid tumors.

Raphael J. Wilson ad36tp@r.postjobfree.com Page 3

PPD Pharmaco, Inc., Austin, TX

Clinical Research Associate-Mentor

Served as the primary contact for trainees, provided new hire training and therapeutic developmental training for new team member acquisition.

Clinical Research Associate

Managed and monitored multiple investigative sites nationally with most frequent sites in TX, LA, AL, AZ, OK, MO, NM, CO, FL, NC, TN, OR, WA, N. California, CT, MN, ID. Participated in the conduct of multi-center clinical research studies, reviewed project- related materials and literature to develop a basic understanding of the protocol and therapeutic areas.

US Dept of Justice, Federal Bureau of Prisons-FPC Bryan, Bryan, TX

Health Services Medical Officer Infectious Disease Coordinator

Developed and implemented policies and procedures for the TB, HIV, Hepatitis and STD programs for the institution.

Health Services Medical Officer

Provided full-service ambulatory health care to the inmate population, diagnosed and treated disease states and emergency medical conditions. Developed and conducted chronic care clinic providing medical care to +1500 inmate patients.

EDUCATION

Medical Doctorate

Ross University School of Medicine, Miramar, Florida

Concentration: Medical Doctorate

Meharry Medical College Nashville, TN

Concentration: Bachelor of Science, Chemistry

Saint Louis University, St. Louis, MO

BOARD CERTIFICATIONS

Certificate of Completion Digital Health HARVARD LEARNING ONLINE - Nov 2022 Credential ID 22BC-BP49-REDW

Board Certified Medical Affairs Specialist – BCMAS - The Accreditation Council for Medical Affairs (ACMA) 2020 - 2025

Professional Certification in Medicines Development – CMD - International Federation of Associations of Pharmaceutical Physicians (IFAPP)/Kings College London 2021

PROFESSIONAL ORGANIZATIONS

Member Academy of Physicians in Clinical Research (APCR) 2019 - Present

Member (2012 – Present); Affiliate Member (2017 – Present) American College of Cardiology

Member Association of Black Cardiologist (2017 – Present)

Member American Society for Preventive Cardiology American Society of Hypertension (2010 – 2017)

Member Drug Information Association (2009 – Present)

Member SoCal Pharmaceutical Medicine Group (Formerly AAPP Western Chapter) (2005 – Present)

Professional Member American Diabetes Association (2003 – Present)

Member Professional and Educational Development committee-Member 2002-2005

Member American Academy of Pharmaceutical Physicians (1997 – 2005)

Member Association of Clinical Research Professionals (1997 – 2012)

Fellow American College of International Physicians (1996 – Present)

Contact this candidate